UB Paderborn / Katalog / Suche / in CDI

Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

Cancers, 2023-08, Vol.15 (17), p.4237

2023

Volltextzugriff (PDF)

Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group

Cancer treatment reviews, 2024-05, Vol.126, p.102734-102734, Article 102734

2024

Volltextzugriff (PDF)

Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

Critical reviews in oncology/hematology, 2022-12, Vol.180, p.103826-103826, Article 103826

2022

Volltextzugriff (PDF)

Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma

Leukemia & lymphoma, 2016-06, Vol.57 (6), p.1467-1470

2016

Volltextzugriff (PDF)

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

Journal of clinical oncology, 1996-02, Vol.14 (2), p.351-356

1996

Volltextzugriff (PDF)

Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma

American journal of clinical oncology, 1994-08, Vol.17 (4), p.294-297

1994

Volltextzugriff (PDF)

High-risk early-stage ovarian cancer : randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy

American journal of clinical oncology, 1994-02, Vol.17 (1), p.72-76

1994

Volltextzugriff (PDF)

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

Journal of clinical oncology, 1991-04, Vol.9 (4), p.658-663

1991

Volltextzugriff (PDF)

A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

Journal of clinical oncology, 1986-06, Vol.4 (6), p.965-971

1986

Volltextzugriff (PDF)

The treatment of progressive ovarian carcinoma with D-Trp-LHRH (decapeptyl)

European journal of cancer (1990), 1994, Vol.30 (12), p.1903-1904

1994

Volltextzugriff (PDF)

Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer

European journal of cancer (1990), 1994, Vol.30 (4), p.449-452

1994

Volltextzugriff (PDF)

Intraperitoneal chemotherapy with carboplatin and interferon alpha in the treatment of relapsed ovarian cancer: a pilot study

Anticancer research, 1991-07, Vol.11 (4), p.1641

1991

Volltextzugriff (PDF)

Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival

Cancer, 1989-09, Vol.64 (6), p.1188-1191

1989

Volltextzugriff (PDF)

Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens

European journal of cancer (1990), 1993, Vol.29A (4), p.652-652

1993

Volltextzugriff (PDF)

Crossover study with cisplatin or carboplatin in advanced ovarian cancer

Gynecologic oncology, 1990-11, Vol.39 (2), p.146-149

1990

Volltextzugriff (PDF)

Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma

European journal of cancer (1990), 1992-01, Vol.28 (6), p.1079-1080

1992

Volltextzugriff (PDF)

Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancer

Tumori, 1988-08, Vol.74 (4), p.471

1988

Volltextzugriff (PDF)

Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

Gynecologic oncology, 1990-04, Vol.37 (1), p.39-43

1990

Volltextzugriff (PDF)

Uterine sarcomas: a clinicopathologic study

Oncology, 1988, Vol.45 (6), p.428

1988

Volltextzugriff (PDF)

Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987-10, Vol.6 (5), p.380

1987

Volltextzugriff (PDF)

Evaluation of the cochleovestibular function in patients treated with carboplatin for ovarian carcinoma

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986-12, Vol.5 (6), p.411

1986

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma

INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial—the INCA study protocol

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma

High-risk early-stage ovarian cancer : randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

The treatment of progressive ovarian carcinoma with D-Trp-LHRH (decapeptyl)

Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer

Intraperitoneal chemotherapy with carboplatin and interferon alpha in the treatment of relapsed ovarian cancer: a pilot study

Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival

Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens

Crossover study with cisplatin or carboplatin in advanced ovarian cancer

Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma

Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancer

Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

Uterine sarcomas: a clinicopathologic study

Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma

Evaluation of the cochleovestibular function in patients treated with carboplatin for ovarian carcinoma

Aktive Filter

Suchergebnisse filtern